China allows sale of Pfizer oral drug as demand surges in wake of rising COVID cases
The agreement is valid between 14th December and 30th November, 2023, China Meheco said in a filing to the Shanghai stock exchange
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.